The biophore concept

Protein-Ligand Interactions: From Molecular Recognition to Drug Design

Volumn , Issue , 2005, Pages 73-105

  Pickett, Stephen ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

ADME prediction; Biophore concept; Diversity analysis; Drug design; Library design; Pharmacophore detection; Pharmacophore fingerprint; Pharmacophore searching; Pharmacophoric groups

Indexed keywords

HUMAN COMPUTER INTERACTION;

EID: 85052951257     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527601813.ch4     Document Type: Chapter

References (178)

1. H.-J. Böhm and G. Klebe, Angew. Chem. Int. Ed. Engl. 1996, 35, 2588-2614.
2. C.G. Wermuth, C. R. Ganellin, P. Lindberg and L. A. Mitscher, Pure Appl. Chem., 1988, 70, 1129-1143.
3. W. C. Lumma, K.M. Witherup, T. J. Tucker, S.F. Brady, J.T. Sisko, A.M. Naylor-Olsen, S. D. Lewis, R.M. Freidinger, J. Med. Chem. 1998, 41, 1011-1013.
4. T. J. Tucker, S.F. Brady, W.C. Lumma, S. D. Lewis, S. J. Gardell et al., J. Med. Chem. 1998, 41, 3210-3219.
5. P. Ehrlich, Chem. Ber. 1909, 42, 17.
6. E. J. Artens, Progr. Drug Res. 1966, 10, 429.
7. P. Gund, Evolution of the Pharmacophore Concept in Pharmaceutical Research. In Pharmacophore Perception, Development and Use in Drug Design O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA, 2000, 5-11.
8. Y. C. Martin, J. Med. Chem. 1992, 35, 2145-2154.
9. A. C. Good and J. S. Mason, Reviews in Computational Chemistry 1996, 7, 67-117.
10. G.W. A. Milne, M.C. Nicklaus and S. Wang, SAR and QSAR in Environmental Research, 1998, 9, 23-38.
11. A. C. Good, J. S. Mason, S.D. Pickett, Methods Princ. Med. Chem. 10 (Virtual Screening for Bioactive Molecules), 2000, 131-159.
12. Catalyst. Distributed by Accelrys Inc. 9685 Scranton Road, San Diego, CA 92121, USA.
13. J. Greene, S. Kahn, H. Savoj, P. Sprague, S. Teig, J. Chem. Inf. Comput. Sci. 1994, 34, 1297-1308.
14. UNITY® 4.2.1 Tripos, Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA.
15. S. Ash, M.A. Cline, R.W. Homer, T. Hurst, and G.B. Smith, J. Chem. Inf. Comput. Sci., 1997, 37, 71-79.
16. Y. C. Martin, M.G. Bures, E. A. Danaher. J. DeLazzer, I. Lico and P. A. Pavlik, J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
17. G. Jones, P. Willett and R. C. Glen, J. Comput.-Aided Mol. Des. 1995, 9, 532-549.
18. D. Mayer, C.B. Naylor, I. Motoc, G.R. Marshall. J. Comput.-Aided Mol. Des. 1987, 1, 3-16.
19. S.D. Pickett, I.M. McLay and J. S. Mason, J. Chem. Inf. Comput. Sci. 1996, 36, 1214-1233.
20. J. S. Mason, I. Morize, P. R. Menard, D.L. Cheney, C. Hulme and R. F. Labaudiniere. J. Med. Chem. 1999, 42, 3251-3264.
21. G. R. Marshal, C.D. Barry, H. E. Bosshard, R. A. Dammkoehler and D.A. Dunn, in Computer-Assisted Drug Design, Vol. 112, E. C. Olson and R. E. Christofferson eds. American Chemical Society, Washington D. C. 1979, 205-226.
22. R. D. Nelson, D.I. Gottlieb, T.M. Balasubramanian and G. R. Marshall, in Opioid Peptides: Medicinal Chemistry Vol. 69 R. S. Rapaka, G. Barnett and R. L. Hawks eds. Rockville, NIDA Office of Science, 1986, 204-230.
23. Y. Takeuchi, E. F. B. Shands, D.D. Beusen and G. R. Marshall, J. Med. Chem. 1998, 19, 3609-23.
24. D.D. Beusen and G.R. Marshall, in Pharmacophore Perception, Development and Use in Drug Design, O. Guner Ed., International University Line, La Jolla CA 92038-2525 USA. 2000, 21-45.
25. D. Barnum, J. Greene, A. Smellie and P. Sprague, J. Chem. Inf. Comput. Sci., 1996, 36, 563-571.
26. A. Smellie, S. L. Teig and P. Towbin, J. Comput. Chem. 1995, 16, 171-187.
27. A. Smellie, S.D. Kahn and S. L. Teig, J. Chem. Inf. Comput. Sci. 1995, 35, 285-294.
28. A. Smellie, S.D. Kahn and S. L. Teig, J. Chem. Inf. Comput. Sci. 1995, 35, 295-304.
29. A.T. Brint and P. J. Willett, J. Chem. Inf. Comput. Sci. 1987, 27, 152-158.
30. Y. C. Martin, in Pharmacophore Perception, Development and Use in Drug Design O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA. 2000, 49-68.
31. G. Jones and P. Willett, In Pharmacophore Perception, Development and Use in Drug Design O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA. 2000, 85-106.
32. K. S. Haraki, R. S. Sheridan, R. Venkataraghavan, D.A. Dunn and R. McCulloch, Tetrahedron Comp. Meth. 1990, 3, 565-573.
33. S.D. Pickett, J. King-Underwood, I. Wall, B. S. Sherborne unpublished results. Presented at the UK QSAR & Cheminformatics Group Meeting, Horsham, October 2001. http://www.iainm. demon.co.uk/ukqsar_autumn2001.html.
34. O.F. Guner and D. R. Henry, in Pharmacophore Perception, Development and Use in Drug Design O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA. 2000, 193-212.
35. O.F. Guner, R. Hoffmann and H. Li, In Report by Wendy A. Warr on 217th ACS National Meeting and Exposition, Anaheim, California, March 12-25, 1999. London: Wendy Warr & Associates, 1999, 50-53.
36. P.W. Sprague, Perspect. Drug Discovery Des. 1995, 3, 1-20.
37. J. J. Kaminski, D. F. Rane, M. E. Snow, L. Weber, M.L. Rothofsky, S.D. Anderson and S. L. Lin, J. Med. Chem. 1997, 40, 4103-4112.
38. X. Chen, A. Rusinko III, A. Tropsha and S. S. Young, J. Chem. Inf. Comput. Sci. 1999, 39, 887-896.
39. D.M. Hawkins, S. S. Young and A. Rusinko, Quant. Struct.-Act. Relat. 1998, 16, 1-7.
40. C. E. Keefer, E.C. Bigham and S. S. Young. Pharmcophore identification using massive distributed computing. Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26-30, 2001.
41. P. J. Goodford, J. Med. Chem. 1995, 28, 849-857.
42. GRID 20 is available from Molecular Discovery Ltd. http://www.moldiscovery. com/index.html.
43. R. D. Cramer III, D. E. Patterson and J. D. Bunce, J. Am. Chem. Soc. 1988, 110, 5959-67.
44. Y. C. Martin, K.-H. Kim and C.T. Lin. Adv. Quant. Struct.-Prop. Relat. 1996, 1, 1-52.
45. K.-H. Kim, G. Greco and E. Novellino, Perspect. Drug Discovery Des. 12/13/14 (3D QSAR in Drug Design: Recent Advances), 1998, 257-315.
46. U. Norinder, Perspect. Drug Discovery Des. 12/13/14 (3D QSAR in Drug Design: Recent Advances), 1998, 25-39.
47. R. D. Clark, J.M. Leonard and A. Strizhev, in Pharmacophore Perception, Development and Use in Drug Design, O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA. 2000, 151-169.
48. T.T. Talele, S. S. Kulkarni and V.M. Kulkarni, J. Chem. Inf. Comput. Sci. 1999, 39, 958-966.
49. M. Baroni, G. Costantino, G. Cruciani, D. Riganelli, R. Valigi, and S. Clementi, Quant. Struct.-Act. Relat. 1993, 12, 9-20.
50. G. Cruciani and S. Clementi, Methods Princ. Med. Chem. 3 (Advanced Computer-Assisted Techniques in Drug Discovery), 1995, 61-88.
51. Sybyl, developed and distributed by Tripos Inc.
52. M. Pastor, G. Cruciani and S. Clementi, J. Med. Chem. 1997, 40, 1455-1464.
53. M. Pastor, G. Cruciani, I. McLay, S. Pickett and S. Clementi, J. Med. Chem. 2000, 43, 3233-43.
54. ALMOND is available from Multivariate Infometric Analysis S.r.l. http://www.miasrl.com.
55. P. Benedetti, R. Mannhold, G. Cruciani and M. Pastor, J. Med. Chem. 2002, 45, 1577-84.
56. A. J. Hopfinger, S. Wang, J. S. Tokarski, B. Jin, M. Albuquerque, P. J. Madhav and C. Duraiswami, J. Am. Chem. Soc. 1997, 119, 10509-10524.
57. A. C. Good and W. G. Richards, Perspect. Drug Discovery Des. 9/10/11 (3D QSAR in Drug Design: Ligand/Protein Interactions and Molecular Similarity), 1998, 321-338.
58. ASP is a part of the TSAR3D package distributed by Acclerys Inc. http://www.accelrys.com.
59. A. C. Good, E. E. Hodgkin and W.G. Richards, J. Chem. Inf. Comput. Sci. 1992, 32, 188-191.
60. T.D. J. Perkins and P.M. Dean, J. Comput.-Aided Mol. Des. 1993, 7, 155-172.
61. J. E. J. Mills, I. J. P. De Esch, T. D.J. Perkins and P.M. Dean, J. Comput.-Aided Mol. Des. 15, 81-96 (2001).
62. J. E. J. Mills and P.M. Dean, J. Comput.-Aided Mol. Des. 1996, 10, 607-622.
63. F.H. Allen and O. Kennard, Chemical Design Automation News, 1993, 8(1), 1 & 31-37.
64. M.D. Miller, R.P. Sheridan and S. K. Kearsley, J. Med. Chem. 1999, 42, 1505-14.
65. M.D. Miller, E.M. Fluder, L.A. Castonguay, J.C. Culberson, R.T. Mosley, K. Prendergast, S. K. Kearsley and R. P. Sheridan, Med. Chem. Res. 1999, 9, 513-534.
66. M. von Itzstein, W.Y. Wu, G.B. Kok, M.S. Pegg, J. C. Dyason, B. Jin, T.V. Phan, M.L. Smythe, H.F. White et al., Nature 1993, 363, 418-423.
67. H.J. Böhm, J. Comput.-Aided Mol. Des. 1992, 6, 61-78.
68. H.J. Böhm, J. Comput.-Aided Mol. Des. 1992, 6, 593-606.
69. H.J. Böhm, J. Comput.-Aided Mol. Des. 1998, 12, 1-15.
70. D.B. Wigley, G. J. Davies, E. J. Dobson, A. Maxwell and G. Dodson, Nature, 1991, 351, 624-629.
71. L. Brino, A. Urzhumstev, M. Mousli, C. Bronner, A. Mitschler, P. Oudet and D. Moras, J. Biol. Chem. 2000, 275, 9468-9475.
72. M.L. Verdonk, J. C. Cole and R. Taylor, J. Mol. Biol. 1999, 289, 1093-1108.
73. M.L. Verdonk, J. C. Cole, P. Watson, V. Gillet, P. Willett, J. Mol. Biol. 2001, 307, 841-859.
74. I. J. Bruno, J. C. Cole, J. P.M. Lommerse, R. S. Rowland, R. Taylor and M.L. Verdonk, J. Comput.-Aided Mol. Des. 1997, 11, 525-537.
75. D. E. Clark, D.R. Westhead, R. A. Sykes, C.W. Murray, J. Comput.-Aided Mol. Des. 1996, 10, 397-416.
76. P. A. Greenidge, B. Carlsson, L.-G. Bladh and M. Gillner, J. Med. Chem., 1998, 41, 2503-2512.
77. Chem-X was formally developed at Chemical Design (now part of Accelrys Inc.).
78. C.M. Murray and S. J. Cato, J. Chem. Inf. Comput. Sci. 1999, 39, 46-50.
79. E. K. Davies and C. J. Davies, J. Chem. Inf. Comput. Sci., submitted.
80. M.D. Eldridge, C.W. Murray, T.R. Auton, G.V. Paolini and R. P. Mee, J. Comput.-Aided Mol. Des., 1997, 11, 425-445.
81. C.W. Murray, T.R. Auton, and M.D. Eldridge, J. Comput.-Aided Mol. Des. 1998, 12, 503-519.
82. G. Jones, P. Willett, R. C. Glen, A. R. Leach and R. Taylor, J. Mol. Biol. 1997, 267, 727-748.
83. M. Rarey, B. Kramer, T. Lengauer and G. Klebe, J. Mol. Biol. 1996, 261, 470-489.
84. I. D. Kuntz, J.M. Blaney, S. J. Oatley, R. L. Langridge and T. E. Ferrin, J. Mol. Biol. 1982, 161, 269-288.
85. B. K. Shoichet and I. D. Kuntz, Protein Eng. 1993, 6, 723-732.
86. A. Dalby, J.G. Nourse, W. D. Hounshell, D.L. Gushurst, B. A. Leland and J. Laufer, J. Chem. Inf. Comput. Sci. 1992, 32, 244-255.
87. D. Weininger, J. Chem. Inf. Comput. Sci. 1988, 28, 31-36.
88. D. Weininger, A. Weininger and J. L. Weininger, J. Chem. Inf. Comput. Sci. 1989, 29, 97-101.
89. J. Gasteiger, C. Rudolph and J. Sadowski, Tetrahedron Comp. Method. 1990, 3, 537-547.
90. R. S. Pearlman CDA News, 2, 1-7 (1987).
91. A. Rusinko III, J.M. Skell, R. Balducci, C.M. McGarity and R. S. Pearlman. CONCORD, A program for the rapid generation of high quality approximate 3D molecular structures. Distributed by Tripos Inc., 1699 Hanley Road, Suite 303, St. Louis, MO 63144 U.S.A.
92. S. E. Jakes and P. Willett, J. Mol. Graphics, 1986, 4, 12-20.
93. T. E. Moock, D. R. Henry, A.G. Ozkabak and M. Alamgir. J. Chem. Inf. Comput. Sci. 1994, 34, 184-189.
94. ISIS-3D developed and distributed by MDL Information Systems Inc., San Leandro, CA, USA.
95. R. P. Sheridan, R. Nilakantan, A. Rusinko III, N. Bauman, K. S. Haraki, and R. Venkataraghavan, J. Chem. Inf. Comput. Sci., 1989, 29, 255-260.
96. J.H. Van Drie, D. Weininger, Y.C. Martin, J. Comput.-Aided Mol. Des. 1989, 3, 225-251.
97. D. E. Clark, P. Willett and P.W. Kenny, J. Mol. Graphics 1992, 10, 194-204.
98. D. E. Clark, P. Willett, and P.W. Kenny, J. Mol. Graphics, 1993, 11, 146-156.
99. D. E. Clark, G. Jones, P. Willett, P.W. Kenny, and R. C. Glen, J. Chem. Inf. Comput. Sci. 1994, 34, 197-206.
100. T. Hurst, J. Chem. Inf. Comput. Sci. 1994, 34, 190-196.
101. N.W. Murrall and E. K. Davies, J. Chem. Inf. Comput. Sci. 1990, 30, 312-316.
102. M. Hahn, J. Chem. Inf. Comput. Sci., 1997, 37, 80-86.
103. M. Hahn and D. Rogers, J. Med. Chem. 1995, 38, 2080-2090.
104. O.F. Guner, M. Waldman, R. Hoffmann and J.-H. Kim, in Pharmacophore Perception, Development and Use in Drug Design O. Guner Ed. International University Line, La Jolla CA 92038-2525 USA. 2000, 213-236.
105. T. Hurst. Partial-match 3D searching. Book of Abstracts, 214th ACS National Meeting, Las Vegas, NV, 7-11 September 1997 COMP-037.
106. Daylight Chemical Information Systems Inc., 27401 Los Altos, Suite 370, Mission Viejo, Santa Fe, NM, USA. http://www.daylight.com.
107. SSKEYS Gateway, MDL Information Systems Inc., 14600 Catalina St., San Leandro, CA 94577 http:// www.mdli.com/.
108. S. A. Mousa and D. Cheresh, Drug Discovery Today 1997, 2, 187-199.
109. S.D. Pickett, I.M. McLay and D. E. Clark J. Chem. Inf. Comput. Sci. 2000, 40, 263-272.
110. S. K. Kearsley, S. Sallamack, E.M. Fluder, J.D. Andose, R.T. Mosley, R.P. Sheridan, J. Chem. Inf. Comput. Sci. 1996, 36, 118-127.
111. G. Schneider, W. Neidhart, T. Giller and G. Schmid, Angew. Chem. Int. Ed. 1999, 38, 2894-96.
112. R. D. Brown and Y. C. Martin, J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
113. E. K. Davies, in Molecular Diversity and Combinatorial Chemistry: Libraries and Drug Discovery, I.M. Chaiken and K.D. Janda Eds. American Chemical Society, Washington D.C., 1996, 309-316.
114. J. S. Mason, I. Morize, P. R. Menard, D.L. Cheney, C. Hulme and R. F. Labaudiniere, J. Med. Chem. 1999, 42, 3251-3264.
115. P. Willett, J.M. Barnard and G.M. Downs. J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
116. A. Pozzan, A. Feriani, G. Tedesco and A.M. Capelli, Proceedings of QSAR 2000, Prous Science S. A. 2000.
117. P. C. Astles, T. J. Brown, C.M. Handscombe, M.F. Harper, N.V. Harris, R. A. Lewis, P.M. Lockey, C. McCarthy, I.M. McLay, B. Porter, A.G. Roach, C. Smith and R. J. A. Walsh, Eur. J. Med. Chem. 1997, 32, 409-423.
118. P. C. Astles, C. Brealey, T. J. Brown, V. Facchini, C. Handscombe, N.V. Harris, C. McCarthy, I.M. McLay, B. Porter, A.G. Roach, C. Sargent, C. Smith and R. J. A. Walsh, J. Med. Chem. 1998, 41, 2732-2744.
119. P. C. Astles, T. J. Brown, F. Halley, C.M. Handscombe, N.V. Harris, T.N. Majid, C. McCarthy, I.M. McLay, A. Morley, B. Porter, A.G. Roach, C. Sar gent, C. Smith, and R. J. A. Walsh, J. Med. Chem. 2000, 43, 900-910.
120. D.P. Marriott, I. G. Dougall, P. Meghani, Y.-J. Liu and D. R. Flower, J. Med. Chem. 1999, 42, 3210-3216.
121. H. Hong, N. Neamati, S. Wang, M.C. Nicklaus, A. Mazumder, H. Zhao, T. R. Burke Jr., Y. Pommier and G.W. A. Milne, J. Med. Chem. 1997, 40, 930-936.
122. S. Wang, G.W. A. Milne, X. Yan, I. J. Posey, M.C. Nicklaus, L. Graham and W. G. Rice, J. Med. Chem. 1996, 39, 2047-2054.
123. S. Wang, D.W. Zaharevitz, R. Sharma, V. E. Marquez, N. E. Lewin, L. Du, P.M. Blumberg and G.W. A. Milne, J. Med. Chem. 1994, 37, 4479-4489.
124. D.W. Zaharevitz, R. Gussio, A. Wiegand, R. Jalluri, N. Pattabiraman, G. E. Kellogg, L. A. Pallansch, S. S. Yang and R.W. Buckheit Jr, Med. Chem. Res. 1999, 9, 551-564.
125. D.K. Agrafiotis, in The Encyclopedia of Computational Chemistry, P. v. R. Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer III, P. R. Schreiner eds., John Wiley & Sons: Chichester, Vol. 1, 1998, 742-761.
126. R. A. Lewis and P.M. Dean eds. Molecular Diversity in Drug Design, Kluwer Academic Publishers, Dordrecht, Netherlands, 1999.
127. R. A. Lewis, S. D. Pickett and D. E. Clark, in Reviews in Computational Chemistry, K. B. Lipkowitz and D.B. Boyd eds., Vol. 16, Wiley-VCH, John Wiley & Sons Inc., New York, 2000, 1-51.
128. A. K. Ghose, V. N. Viswanadhan and J. J. Wendoloski, in Combinatorial Library Design and Evaluation: Principles, Software Tools, and Applications in Drug Discovery, A. K. Ghose, V. N. Viswanadhan eds. Marcel Dekker, Inc., New York, 2001, 51-71.
129. J. S. Mason and S.D. Pickett, Perspect. Drug Discovery Des. 1997, 7/8, 85-114.
130. S.D. Pickett, C. Luttmann, V. Guerin, A. Laoui and E. James, J. Chem. Inf. Comput. Sci. 1998, 38, 144-150.
131. R. A. Lewis, A. C. Good and S. D. Pickett, in Computer-Assisted Lead Finding and Optimization: Current Tools for Medicinal Chemistry, H. van de Waterbeemd, B. Testa and G. Folkers eds., Wiley-VCH, Weinheim, 1997, 135-156.
132. A. C. Good and R. A. Lewis, J. Med. Chem. 1997, 40, 3926-3936.
133. J. S. Mason and B. R. Beno, J. Mol. Graph. Mod. 2000, 18, 438-451.
134. R. S. Pearlman and K.M. Smith, Perspect. Drug Discovery Des. 1998, 9, 339-353.
135. M.J. McGregor and S.M. Muskal, J. Chem. Inf. Comput. Sci. 2000, 40, 117-125.
136. MDL Information Systems, Inc. 14600 Catalina St., San Leandro, CA 94577. http://www.mdli.com.
137. E. J. Martin and T. J. Hoeffel, J. Mol. Graphics Modell. 2000, 18, 383-403.
138. A. R. Leach, D.V. S. Green, M.M. Hann, D.B. Judd and A. C. Good, J. Chem. Inf. Comput. Sci. 2000, 40, 1262-1269.
139. D.B. Judd, A. R. Leach, M.M. Hann, D.V. S. Green and A. C. Good, Book of Abstracts, 219th ACS National Meeting, San Francisco, CA, March 26-30, 2000.
140. V. Gillet, A. P. Johnson, P. Mata, S. Sike and P. Williams, SPROUT: A program for structure generation. J. Comput.-Aided Mol. Des. 1993, 7, 127-153.
141. V. J. Gillet, G. Myatt, Z. Zsoldos and A. P. Johnson, Perspect. Drug Discovery Des. 1995, 3, 34-50.
142. Q. Han, C. Dominguez, P. F.W. Stouten, J.M. Park, D. E. Duffy, R.A. Galemmo Jr., K. A. Rossi, R. S. Alexander, A.M. Smallwood, P. C. Wong, M.M. Wright, J.M. Luettgen, R.M. Knabb and R. R. Wexler, J. Med. Chem. 2000, 43, 4398-4415.
143. A. P. Johnson, K. Boda, J.-F. Marchaland and A. Ting, Book of Abstracts, 219th ACS National Meeting, San Francisco, CA, March 26-30, 2000.
144. N.P. Todorov and P.M. Dean, J. Comput.-Aided Mol. Des. 1997, 11, 175-192.
145. D.L. Cheney, J.S. Mason, M.R. Becker, R.W. Ewing, H.W. Pauls, N. Todorov, 215th ACS National Meeting, Dallas, March 29. April 2 1998.
146. H.J. Böhm, in Computer-Assisted Lead Finding and Optimization, H. van de Waterbeemd, B. Testa and G. Folkers eds. Wiley-VCH, 1997, 125-133.
147. H.-J. Böhm, D.W. Banner and L. Weber, J. Comput.-Aided Mol. Des. 1999, 13, 51-56.
148. H.-J. Böhm, M. Boehringer, D. Bur, H. Gmuender, W. Huber, W. Klaus, D. Kostrewa, H. Kuehne, T. Luebbers, N. Meunier-Keller, and F. Mueller, J. Med. Chem. 2000, 43, 2664-2674.
149. J. S. Mason and D.L. Cheney, Proc. Pac. Symp. Biocomput. 1999, 4, 456-467.
150. J. S. Mason and D.L. Cheney, Proc. Pac. Symp. Biocomput. 2000, 5, 576-587.
151. J. E. Eksterowicz, E. Evensen, C. Lemmen, G.P. Brady, J.K. Lanctot, E. K. Bradley, E. Saiah, L. A. Robinson, P. D. J. Grootenhuis and J.M. Blaney, J. Mol. Graphics Mod. 2002, 20, 469-477.
152. S. L. Teig, J. Biomol. Screening 1998, 3, 85-88.
153. M.H. Tarbit and J. Berman, Curr. Opin. Chem. Biol. 1998, 2, 411-416.
154. D. E. Clark and S.D. Pickett, Drug Discovery Today 2000, 2, 49-58.
155. P. J. Eddershaw, A.P. Beresford and M.K. Bayliss, Drug Discovery Today 2000, 5, 409-414.
156. H. E. Selick, A. P. Beresford and M.H. Tarbit, Drug Discovery Today 2002, 7, 109-116.
157. S. A. Wrighton and J. C. Stevens, Crit. Rev. Toxicol. 1992, 22, 1-21.
158. D.A. Smith, M.J. Ackland and B. C. Jones, Drug Discovery Today, 1997, 2, 406-414.
159. D.A. Smith, M.J. Ackland and B. C. Jones, Drug Discovery Today, 1997, 2, 479-486.
160. F. P. Guengerich and T. L. MacDonald FASEB J. 1990, 4, 2453-2459.
161. K. R. Korzekwa, J. P. Jones and J. R. Gillette. J. Am. Chem. Soc. 1990, 112, 7042-46.
162. N.A. Hosea, G. P. Miller and F. P. Guengerich, Biochemistry, 2000, 39, 5929-5939.
163. G. R. Strobl, S. von Kruedener, J. Stockigt, F.P. Gungerich and T. Wolff, J. Med. Chem. 1993, 36, 1136-1145.
164. S. Ekins, G. Bravi, S. Binkley, J.S. Gillespie, B. J. Ring, J.H. Wikel and S. A. Wrighton, J. Pharmacol. Exp. Ther., 1999, 290, 429-438.
165. S. Ekins, G. Bravi, J.H. Wikel and S. A. Wrighton, J. Pharmacol. Exp. Ther., 1999, 291, 424-433.
166. S. Ekins, G. Bravi, S. Binkley, J.S. Gillespie, B. J. Ring, J.H. Wikel and S. A. Wrighton, Pharmacogenetics 1999, 9, 477-489.
167. S. Ekins, G. Bravi, B. J. Ring, T. A. Gillespie, J. S. Gillespie, M. Vandenbranden, S. A. Wrighton and J.H. Wikel, J. Pharmacol. Exp. Ther. 1999, 288, 21-29.
168. S. Ekins, G. Bravi, S. Binkley, J. Gillespie, B. Ring, J. Wikel and S. Wrighton, Drug Metab. Disp. 2000, 28, 994-1002.
169. M.J. de Groot, M.J. Ackland, V. A. Horne, A. A. Alex, B. C. Jones, J. Med. Chem. 1999, 42, 1515-1524.
170. M.J. de Groot, M.J. Ackland, V. A. Horne, A. A. Alex and B. C. Jones, J. Med. Chem. 1999, 42, 4062-4070.
171. P. A. Williams, J. Cosme, V. Sridhar, E. F. Johnson, and D. E. McRee, Mol. Cell. 2000, 5, 121-131.
172. M.J. de Groot, A. A. Alex and B. C. Jones, J. Med. Chem. 2002, 45, 1983-1993.
173. L. Afzelius, I. Zamora, M. Riddrestrom, T. B. Andersson, A. Karlen and C.M. Masimimermbwa, Mol. Pharmacol. 2001, 59, 909-919.
174. J. E. Penzotti, M.L. Lamb, E. Evensen and P. D.J. Grootenhuis, J. Med. Chem. 2002, 45, 1737-1740.
175. A. A. Seelig, Eur. J. Biochem. 1998, 251, 252-261.
176. J.M. Lehman et al., J. Clin. Invest. 1998, 102, 1016-1023.
177. S. Ekins and J. A. Erickson, Drug Metab. Dispos. 2002, 30, 1-4.
178. R. E. Watkins et al., Science 2001, 292, 2392-2333.